Inogen Stock News

Inogen, Inc. (NASDAQ:INGN) reached a new 52-week low during trading on Friday . The stock traded as low as $31.50 and last traded at $31.52, with a volume of 1373 shares. The stock had previously closed at $33.56. Several research firms have recently commented on INGN. SVB Leerink reduced their price target on Inogen from []

Metropolitan Life Insurance Co NY boosted its holdings in shares of Inogen, Inc. (NASDAQ:INGN) by 115,400.0% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,775 shares of the medical technology companys stock after buying an additional 5,770 shares during the period. Metropolitan []

AQR Capital Management LLC grew its holdings in Inogen, Inc. (NASDAQ:INGN) by 43.5% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 28,321 shares of the medical technology companys stock after acquiring an additional 8,582 shares during the period. AQR Capital Management []

Inogen, Inc. (INGN) CEO Nabil Shabshab on Q3 2021 Results - Earnings Call Transcript

Inogen's (INGN) third-quarter results benefit from higher revenues across its segments.

Inogen (INGN) delivered earnings and revenue surprises of 282.76% and 9.04%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release thir

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), (“Inogen” or “the Company”), a medical technology company offering innovative respiratory products for use in the homecare setting

Investors continue to be optimistic about Inogen (INGN) on its potential in the POC space and a strong product portfolio.

Inogen's (INGN) second-quarter results benefit from higher revenues across its segments.

Inogen Inc (NASDAQ: INGN) reported Q2 revenue of $101.6 million, +41.7% Y/Y, beating the consensus of $88.75 million. The sales growth was driven primarily due to strong consumer demand, improved av

Shares of Inogen Inc. plunged to pace all decliners Thursday, after the portable oxygen container (POC) company reported a surprise second-quarter profit and a big revenue beat, but warned that the se

Inogen, Inc. (INGN) CEO Nabil Shabshab on Q2 2021 Results - Earnings Call Transcript

Inogen (INGN) delivered earnings and revenue surprises of 269.23% and 15.22%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release seco